05.13.22 -- Innovative Learning Events And Opportunities

September 20 and 21 | Arlington, VA

At the DIA 2022 Biosimilars Conference, manufacturers, regulators, payers, prescribers, and patients will come together to discuss factors that influence biosimilar development and access and to share perspectives on what success and equilibrium will look like. They’ll apply the newest thinking and relevant learnings from global regions to build strategies for continuing the growth of the biosimilars market and bringing these important biologic therapies — and cost savings — to patients.

 

October 13 and 14 | Garden Grove, CA

DIA’s Digital Technology in Clinical Trials Conference will bring together thought leaders from regulatory agencies, biotech, pharma, patients, and academia to discuss the latest advances, challenges, and forward-thinking approaches for implementing digital technology to improve clinical trials. While the conference will focus on the impact of digitalization in clinical trials today, we will make time to explore future applications and how they may enable the clinical trials of tomorrow.

 

October 27 and 28 | Tysons Corner, VA

The DIA’s Complex Generic Drug-Device Combination Products Conference will examine current knowledge and ongoing scientific research where industry, regulators, and stakeholders discuss today’s best answers and solutions to key questions regarding the development of complex generic drug-device combination products.